Cargando…
Decitabine and Cisplatin are Synergistic to Exert Anti-Tumor Effect on Gastric Cancer via Inducing Sox2 DNA Demethylation
BACKGROUND: Cisplatin is a vital chemotherapy regimen for gastric cancer (GC), while partial response is observed (approximately 40%) because of drug resistance. Thus, it is urgent to improve drug sensitivity to improve the therapeutic effect of cisplatin on GC. PURPOSE: The study was performed to e...
Autores principales: | Zhu, Zhipeng, Lin, Sihao, Wu, Xiaofang, Xu, Jiuhua, Li, Lulu, Ye, Weipeng, Li, Jiayi, Huang, Zhengjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837578/ https://www.ncbi.nlm.nih.gov/pubmed/33519210 http://dx.doi.org/10.2147/OTT.S276168 |
Ejemplares similares
-
In Silico Identification of Contradictory Role of ADAMTS5 in
Hepatocellular Carcinoma
por: Zhu, Zhipeng, et al.
Publicado: (2021) -
Comprehensive analysis reveals a prognostic and therapeutic biomarker CD3D in the breast carcinoma microenvironment
por: Zhu, Zhipeng, et al.
Publicado: (2021) -
Effect of gastric cancer stem cell on gastric cancer invasion, migration and angiogenesis
por: Zhu, Zhipeng, et al.
Publicado: (2020) -
Laparoscopic versus open approach in gastrectomy for advanced gastric cancer: a systematic review
por: Zhu, Zhipeng, et al.
Publicado: (2020) -
Comprehensive analysis reveals CTHRC1, SERPINE1, VCAN and UPK1B as the novel prognostic markers in gastric cancer
por: Zhu, Zhipeng, et al.
Publicado: (2020)